Tango Therapeutics share price logo

Tango Therapeutics

NASDAQ: TNGX

Mid Cap

$23.34

-1.94

(-7.67%)

as on

Tango Therapeutics Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $23.27
    $25.09
    downward going graph

    0.30%

    Downside

    7.50%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.25
    $34.39
    downward going graph

    73.22%

    Downside

    47.34%

    Upside

    downward going graph

Tango Therapeutics share price movements today

Previous Close
$25.28
Open
$25.09
Volume
1.2M
Market Cap
$4.3B
Day's Low - High
$23.27 - $25.09
52 Week Low - High
$6.25 - $34.39

Tango Therapeutics Historical Returns

1 Month Return
-5.14 %
3 Month Return
+ 26.4 %
1 Year Return
+ 270.67 %
3 Year Return
+ 249.17 %
5 Year Return
+ 99.06 %

Tango Therapeutics Stock Fundamentals & Key Indicators

Check Tango Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3B

EPS (TTM)

-0.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-29.14

Industry PE ratio

-12.87

PEG Ratio

-0.7347070054150644

EBITDA

-122.3M

Revenue (TTM)

53.8M

Profit Margin

98.25%

Return On Equity TTM

-25.74%

Tango Therapeutics Stock Valuation

Track how Tango Therapeutics P/E has moved over time to understand its valuation trends.

Tango Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-11.67x)

December 31, 2021

Industry (-12.87x)

December 31, 2025

Today (-10.18x)

December 31, 2025

Highest (-2.60x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -10.18x

Tango Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tango Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.3B99.06%-29.1498.25%NA
BUY$46.2B675.69%NA0.00%NA
BUY$138.7B173.88%31.9286.04%NA
BUY$59.7B-62.65%-7.98-12.57%NA
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Tango Therapeutics Stock including INR - Dollar returns

The Tango Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Tango Therapeutics investment value today

Current value as on today

₹3,72,614

Returns

₹2,72,614

(+272.61%)

Returns from Tango Therapeutics Stock

₹2,42,229 (+242.23%)

Dollar Impact

₹30,386 (+30.39%)

Analyst Recommendation on Tango Therapeutics Stock

Based on 10 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 10 analysts, 100% of analysts recommend a 'BUY' rating for Tango Therapeutics. Average target price of $44.75

Tango Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Tango Therapeutics.

What analysts predicted

47.84%UPSIDE

Target Price

$44.75

Current Price

$23.34

Analyzed by

10 Analysts

Target

$44.75

Tango Therapeutics target price $44.75, a slight upside of 47.84% compared to current price of $23.34. According to 10 analysts rating.

Indian Investors' Interest in Tango Therapeutics Stock

Search interest for Tango Therapeutics Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:4% versus previous 30 day period

Tango Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
6
19
11
4
5
3
53
-
-
-
Gross Profit
6
19
11
4
5
2
53
0
0
-
Operating Income
-42
-29
-32
-40
-42
-40
14
-41
-48
-59
EBITDA
-37
-24
-28
-37
-39
-38
16
-38
-45
-55
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-37
-25
-29
-37
-39
-38
15
-38
-45
-55
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-37
-25
-29
-37
-39
-38
15
-38
-45
-55
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
80.35%
100.00%
0.00%
0.00%
0.00%

Tango Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
24
7
37
24
36
42
62
Gross Profit
-7
6
37
24
36
42
60
Operating Income
-15
-52
-58
-111
-114
-145
-111
EBITDA
-14
-50
-57
-106
-99
-127
-99
Interest Expense
-
-
-
-
-
-
-
Depreciation
0
1
0
1
2
2
2
Income Before Tax
-14
-51
-57
-108
-101
-130
-101
Income Tax Expense
-
-
0
0
0
0
0
Net Income
-14
-51
-58
-108
-101
-130
-101
Net Profit Margin
-30.93%
78.77%
100.00%
100.00%
100.00%
100.00%
96.34%

Tango Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-37
-25
-29
-37
-39
-38
15
-38
-45
-55
Operating Cash Flow
-37
-23
-33
-36
-41
-36
-30
-29
-44
-38
Investing Cash Flow
-11
12
32
52
30
16
47
-135
9
-445
Financing Cash Flow
42
1
2
0
0
0
2
219
79
672
Change in Cash
-6
-9
1
16
-11
-19
19
53
45
187

Tango Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-51
-58
-108
-101
-130
-101
Operating Cash Flow
-24
70
-59
-109
-117
-131
-138
Investing Cash Flow
0
-145
-183
26
41
86
-40
Financing Cash Flow
11
80
357
1
82
47
222
Change in Cash
25
5
114
-81
5
2
42

Mutual Funds that own Tango Therapeutics Stock

Check out the Mutual Funds with significant holdings in Tango Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.980814%
5025962
Fidelity Salem Street Trust
0.741643%
1250488
Fidelity Concord Street Trust
0.726334%
1224676
Fidelity Securities Fund
0.478203%
806300
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
0.378675%
638486

Global Institutional Holdings in Tango Therapeutics

Funds
Holdings
Andrew J.M. Spokes
7.28%
Vanguard
4.26%
iShares
3.84%
James E. Flynn
2.49%
Michael Rockefeller
2.37%

Insights on Tango Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.18M → 53.81M (in $), with an average increase of 94.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TNGX stock has moved up by 109.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TNGX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 225.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 15.88M → -55.34M (in $), with an average decrease of 127.7% per quarter

About Tango Therapeutics

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
OrganisationTango Therapeutics
Headquarters201 Brookline Avenue, Boston, MA, United States, 02215
IndustryBiotechnology
CEODr. Barbara L. Weber M.D.
E-voting on sharesClick here to vote

Key Management of Tango Therapeutics

Name

Title

Ms. Elizabeth Pingpank Hickin

VP of IR & Corporate Communications

Ms. Julie Carretero

Chief Human Resources Officer

Dr. Barbara L. Weber M.D.

Executive Officer

Ms. Daniella Beckman CPA

Executive Officer

Dr. Adam S. Crystal M.D., Ph.D.

President of Research & Development

Mr. Matthew Gall M.B.A.

Chief Financial Officer

Mr. Jannik N. Andersen Ph.D.

Chief Scientific Officer

Ms. Julie Fogarty

Senior VP, General Counsel & Corporate Secretary

Dr. Philippe Serrano

Chief Regulatory Officer

Dr. Janice Kapty Ph.D.

Senior Vice President of Corporate Strategy & Project Leadership

FAQs

What is Tango Therapeutics share price today?

Tango Therapeutics share price today is $23.34 as on at the close of the market. Tango Therapeutics share today touched a day high of $25.09 and a low of $23.27.

What is the 52 week high and 52 week low for Tango Therapeutics share?

Tango Therapeutics share touched a 52 week high of $34.39 on and a 52 week low of $6.25 on . Tango Therapeutics stock price today i.e. is closed at $23.34,which is 32.13% down from its 52 week high and 273.44% up from its 52 week low.

What is Tango Therapeutics's market capitalisation today?

Tango Therapeutics market capitalisation is $0.00T as on .

How to invest in Tango Therapeutics Stock (TNGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tango Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tango Therapeutics Shares that will get you 0.0643 shares as per Tango Therapeutics share price of $23.34 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Tango Therapeutics Stock (TNGX) from India?

Indian investors can start investing in Tango Therapeutics (TNGX) shares with as little as ₹95.368 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in Tango Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Tango Therapeutics share’s latest price of $23.34 as on August 29, 2026 at 8:46 am IST, you will get 0.4284 shares of Tango Therapeutics. Learn more about fractional shares .

What are the returns that Tango Therapeutics has given to Indian investors in the last 5 years?

Tango Therapeutics stock has given 99.06% share price returns and 30.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?